Epidemiology

Estimates of the prevalence and incidence of FTD vary widely, due in part to methodological differences between studies.[21] In a study in Cambridge, UK, data derived from the records of specialty clinics and hospitals in several communities showed a prevalence of 15 cases of FTD per 100,000 in adults ages 45 to 64 years.[1] In the Zuid-Holland province of the Netherlands, data derived from annual surveys of all neurologists and physicians gave a prevalence of 6.7 cases per 100,000 in the 45-to-64 age group.[2] Age-specific prevalence rates were also calculated: 1.2 per 100,000 in the 40-to-49 age group; 3.6 per 100,000 in the 50-to-59 age group; 9.4 per 100,000 in the 60-to-69 age group; and 3.8 in the 70-to-79 age group.[2] These two studies reported mean age at onset to be 53 and 58 years, respectively. Behavioral variant FTD is reported to be four times as common as the primary progressive aphasias.[21]

One systematic review reported that FTD accounted for an average of 2.7% of all dementia cases in prevalence studies that included people ages 65 years and older, and 10.2% of dementia cases in studies that included only people younger than 65 years.[21] Analysis of brain bank data produced estimates that FTD accounts for 8% to 17% of all dementia cases, but brain bank samples are highly selected samples and so estimates derived from these sources are likely to be biased.[22][23]

The typical early age at onset does not imply that FTD is an exclusively early-onset form of dementia. In routine clinical practice, FTD is more often recognized in people ages over 65 years, although diagnosis may be delayed by up to 6 years from symptom onset.[24] A matched retrospective cohort study of patients with FTD presenting before the age of 65 years (19 patients) or after this age (11 patients) found that the older patients more often showed memory impairment, with more frequent hippocampal sclerosis, but had less severe frontal lobe atrophy.[25] A large retrospective cohort study found that the mean age of onset was earlier than 65 years in patients with mutations in the MAPT, GRN, or C9orf72 genes. The presence of a MAPT mutation was associated with earliest onset, with a mean age of onset of 49.5 years and earliest age of onset of 24 years. Age of onset in the second generation was lower than in the first generation.[26]

FTD has been reported to affect men and women equally in some studies, whereas other studies have shown a male preponderance.[3][21][27] One large retrospective cohort study reported a higher prevalence in women among FTD patients with GRN (bit not MAPT or C9orf72) mutations, and that age at onset was later in women than in men among patients with GRN or C9orf72 mutations.[26] There is some evidence that the prevalence of FTD may vary in different ethnic groups.[28]

Use of this content is subject to our disclaimer